Records containing: Multiple Sclerosis (Relapsing Remitting)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-18Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-11-19Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis: an Observational Study
-
CLINICAL_TRIALS study record update · 2025-10-31RESET-MS: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Participants With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2017-04-21A 12 Month Study, With a 6-month, Double-blind, Randomized, Placebo-controlled, Multi-center Parallel- Groups, Treatment Phase Evaluating Efficacy and Safety of Fingolimod 0.5 mg and a 6-month, Open-label, Treatment Phase, in Chinese Patients With Relapsing-remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2014-12-02Multiple Sclerosis - Inflammatory, Neurological and Muscular Adaptations to Progressive Resistance Training
- Organize your saved records without ads with Plus.